Global Antisense Oligonucleotide (ASO) Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Antisense Oligonucleotide (ASO) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antisense Oligonucleotide (ASO) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antisense Oligonucleotide (ASO) Therapeutics market in any manner.
Global Antisense Oligonucleotide (ASO) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ionis Pharmaceuticals, Inc
Sarpeta Therapeutics Inc.
Biogen Inc
Alnylam Pharmaceuticals, Inc
Antisense Therapeutics Limited
Arrowhead Pharmaceuticals Inc.
Enzon Pharmaceuticals, Inc.
Bio-Path Holdings, Inc.
GlaxoSmithKline PLC
Geron Corporation (Geron)
Market Segmentation (by Type)
Pulmonary Delivery
Intravenous Injections
Intradermal Injections
Intraperitoneal Injections
Topical Delivery
Others
Market Segmentation (by Application)
Genetic Disorders
Neurological Disorders
Oncological Disorders
Metabolic Disorders
Ophthalmic Disorders
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Antisense Oligonucleotide (ASO) Therapeutics Market
%li%Overview of the regional outlook of the Antisense Oligonucleotide (ASO) Therapeutics Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antisense Oligonucleotide (ASO) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Antisense Oligonucleotide (ASO) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antisense Oligonucleotide (ASO) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antisense Oligonucleotide (ASO) Therapeutics market in any manner.
Global Antisense Oligonucleotide (ASO) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ionis Pharmaceuticals, Inc
Sarpeta Therapeutics Inc.
Biogen Inc
Alnylam Pharmaceuticals, Inc
Antisense Therapeutics Limited
Arrowhead Pharmaceuticals Inc.
Enzon Pharmaceuticals, Inc.
Bio-Path Holdings, Inc.
GlaxoSmithKline PLC
Geron Corporation (Geron)
Market Segmentation (by Type)
Pulmonary Delivery
Intravenous Injections
Intradermal Injections
Intraperitoneal Injections
Topical Delivery
Others
Market Segmentation (by Application)
Genetic Disorders
Neurological Disorders
Oncological Disorders
Metabolic Disorders
Ophthalmic Disorders
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Antisense Oligonucleotide (ASO) Therapeutics Market
%li%Overview of the regional outlook of the Antisense Oligonucleotide (ASO) Therapeutics Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antisense Oligonucleotide (ASO) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antisense Oligonucleotide (ASO) Therapeutics
1.2 Key Market Segments
1.2.1 Antisense Oligonucleotide (ASO) Therapeutics Segment by Type
1.2.2 Antisense Oligonucleotide (ASO) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antisense Oligonucleotide (ASO) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Antisense Oligonucleotide (ASO) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antisense Oligonucleotide (ASO) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antisense Oligonucleotide (ASO) Therapeutics Sales Sites, Area Served, Product Type
3.6 Antisense Oligonucleotide (ASO) Therapeutics Market Competitive Situation and Trends
3.6.1 Antisense Oligonucleotide (ASO) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antisense Oligonucleotide (ASO) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Antisense Oligonucleotide (ASO) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Antisense Oligonucleotide (ASO) Therapeutics Price by Type (2019-2024)
7 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Antisense Oligonucleotide (ASO) Therapeutics Sales Growth Rate by Application (2019-2024)
8 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Region
8.1.1 Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Region
8.1.2 Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Antisense Oligonucleotide (ASO) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antisense Oligonucleotide (ASO) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antisense Oligonucleotide (ASO) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ionis Pharmaceuticals, Inc
9.1.1 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.1.2 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.1.3 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.1.4 Ionis Pharmaceuticals, Inc Business Overview
9.1.5 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
9.1.6 Ionis Pharmaceuticals, Inc Recent Developments
9.2 Sarpeta Therapeutics Inc.
9.2.1 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.2.2 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.2.3 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.2.4 Sarpeta Therapeutics Inc. Business Overview
9.2.5 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
9.2.6 Sarpeta Therapeutics Inc. Recent Developments
9.3 Biogen Inc
9.3.1 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.3.2 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.3.3 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.3.4 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
9.3.5 Biogen Inc Business Overview
9.3.6 Biogen Inc Recent Developments
9.4 Alnylam Pharmaceuticals, Inc
9.4.1 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.4.2 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.4.3 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.4.4 Alnylam Pharmaceuticals, Inc Business Overview
9.4.5 Alnylam Pharmaceuticals, Inc Recent Developments
9.5 Antisense Therapeutics Limited
9.5.1 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.5.2 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.5.3 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.5.4 Antisense Therapeutics Limited Business Overview
9.5.5 Antisense Therapeutics Limited Recent Developments
9.6 Arrowhead Pharmaceuticals Inc.
9.6.1 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.6.2 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.6.3 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.6.4 Arrowhead Pharmaceuticals Inc. Business Overview
9.6.5 Arrowhead Pharmaceuticals Inc. Recent Developments
9.7 Enzon Pharmaceuticals, Inc.
9.7.1 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.7.2 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.7.3 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.7.4 Enzon Pharmaceuticals, Inc. Business Overview
9.7.5 Enzon Pharmaceuticals, Inc. Recent Developments
9.8 Bio-Path Holdings, Inc.
9.8.1 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.8.2 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.8.3 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.8.4 Bio-Path Holdings, Inc. Business Overview
9.8.5 Bio-Path Holdings, Inc. Recent Developments
9.9 GlaxoSmithKline PLC
9.9.1 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.9.2 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.9.3 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.9.4 GlaxoSmithKline PLC Business Overview
9.9.5 GlaxoSmithKline PLC Recent Developments
9.10 Geron Corporation (Geron)
9.10.1 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.10.2 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.10.3 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.10.4 Geron Corporation (Geron) Business Overview
9.10.5 Geron Corporation (Geron) Recent Developments
10 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast
10.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Region
10.2.4 South America Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antisense Oligonucleotide (ASO) Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antisense Oligonucleotide (ASO) Therapeutics by Type (2025-2030)
11.1.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antisense Oligonucleotide (ASO) Therapeutics by Type (2025-2030)
11.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antisense Oligonucleotide (ASO) Therapeutics
1.2 Key Market Segments
1.2.1 Antisense Oligonucleotide (ASO) Therapeutics Segment by Type
1.2.2 Antisense Oligonucleotide (ASO) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antisense Oligonucleotide (ASO) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Antisense Oligonucleotide (ASO) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antisense Oligonucleotide (ASO) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antisense Oligonucleotide (ASO) Therapeutics Sales Sites, Area Served, Product Type
3.6 Antisense Oligonucleotide (ASO) Therapeutics Market Competitive Situation and Trends
3.6.1 Antisense Oligonucleotide (ASO) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antisense Oligonucleotide (ASO) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Antisense Oligonucleotide (ASO) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Antisense Oligonucleotide (ASO) Therapeutics Price by Type (2019-2024)
7 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Antisense Oligonucleotide (ASO) Therapeutics Sales Growth Rate by Application (2019-2024)
8 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Region
8.1.1 Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Region
8.1.2 Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Antisense Oligonucleotide (ASO) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antisense Oligonucleotide (ASO) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antisense Oligonucleotide (ASO) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ionis Pharmaceuticals, Inc
9.1.1 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.1.2 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.1.3 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.1.4 Ionis Pharmaceuticals, Inc Business Overview
9.1.5 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
9.1.6 Ionis Pharmaceuticals, Inc Recent Developments
9.2 Sarpeta Therapeutics Inc.
9.2.1 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.2.2 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.2.3 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.2.4 Sarpeta Therapeutics Inc. Business Overview
9.2.5 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
9.2.6 Sarpeta Therapeutics Inc. Recent Developments
9.3 Biogen Inc
9.3.1 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.3.2 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.3.3 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.3.4 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
9.3.5 Biogen Inc Business Overview
9.3.6 Biogen Inc Recent Developments
9.4 Alnylam Pharmaceuticals, Inc
9.4.1 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.4.2 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.4.3 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.4.4 Alnylam Pharmaceuticals, Inc Business Overview
9.4.5 Alnylam Pharmaceuticals, Inc Recent Developments
9.5 Antisense Therapeutics Limited
9.5.1 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.5.2 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.5.3 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.5.4 Antisense Therapeutics Limited Business Overview
9.5.5 Antisense Therapeutics Limited Recent Developments
9.6 Arrowhead Pharmaceuticals Inc.
9.6.1 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.6.2 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.6.3 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.6.4 Arrowhead Pharmaceuticals Inc. Business Overview
9.6.5 Arrowhead Pharmaceuticals Inc. Recent Developments
9.7 Enzon Pharmaceuticals, Inc.
9.7.1 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.7.2 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.7.3 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.7.4 Enzon Pharmaceuticals, Inc. Business Overview
9.7.5 Enzon Pharmaceuticals, Inc. Recent Developments
9.8 Bio-Path Holdings, Inc.
9.8.1 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.8.2 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.8.3 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.8.4 Bio-Path Holdings, Inc. Business Overview
9.8.5 Bio-Path Holdings, Inc. Recent Developments
9.9 GlaxoSmithKline PLC
9.9.1 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.9.2 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.9.3 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.9.4 GlaxoSmithKline PLC Business Overview
9.9.5 GlaxoSmithKline PLC Recent Developments
9.10 Geron Corporation (Geron)
9.10.1 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Basic Information
9.10.2 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Overview
9.10.3 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Market Performance
9.10.4 Geron Corporation (Geron) Business Overview
9.10.5 Geron Corporation (Geron) Recent Developments
10 ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast
10.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Region
10.2.4 South America Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antisense Oligonucleotide (ASO) Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antisense Oligonucleotide (ASO) Therapeutics by Type (2025-2030)
11.1.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antisense Oligonucleotide (ASO) Therapeutics by Type (2025-2030)
11.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antisense Oligonucleotide (ASO) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide (ASO) Therapeutics as of 2022)
Table 10. Global Market Antisense Oligonucleotide (ASO) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antisense Oligonucleotide (ASO) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Antisense Oligonucleotide (ASO) Therapeutics Product Type
Table 13. Global Antisense Oligonucleotide (ASO) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antisense Oligonucleotide (ASO) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antisense Oligonucleotide (ASO) Therapeutics Market Challenges
Table 22. Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Type (K Units)
Table 23. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (M USD)
Table 24. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Antisense Oligonucleotide (ASO) Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) by Application
Table 30. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application
Table 31. Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application (2019-2024)
Table 35. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Antisense Oligonucleotide (ASO) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Antisense Oligonucleotide (ASO) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Antisense Oligonucleotide (ASO) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 44. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 45. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Ionis Pharmaceuticals, Inc Business Overview
Table 47. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
Table 48. Ionis Pharmaceuticals, Inc Recent Developments
Table 49. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 50. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 51. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Sarpeta Therapeutics Inc. Business Overview
Table 53. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
Table 54. Sarpeta Therapeutics Inc. Recent Developments
Table 55. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 56. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 57. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
Table 59. Biogen Inc Business Overview
Table 60. Biogen Inc Recent Developments
Table 61. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 62. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 63. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Alnylam Pharmaceuticals, Inc Business Overview
Table 65. Alnylam Pharmaceuticals, Inc Recent Developments
Table 66. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 67. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 68. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Antisense Therapeutics Limited Business Overview
Table 70. Antisense Therapeutics Limited Recent Developments
Table 71. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 72. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 73. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Arrowhead Pharmaceuticals Inc. Business Overview
Table 75. Arrowhead Pharmaceuticals Inc. Recent Developments
Table 76. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 77. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 78. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Enzon Pharmaceuticals, Inc. Business Overview
Table 80. Enzon Pharmaceuticals, Inc. Recent Developments
Table 81. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 82. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 83. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Bio-Path Holdings, Inc. Business Overview
Table 85. Bio-Path Holdings, Inc. Recent Developments
Table 86. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 87. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 88. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GlaxoSmithKline PLC Business Overview
Table 90. GlaxoSmithKline PLC Recent Developments
Table 91. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 92. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 93. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Geron Corporation (Geron) Business Overview
Table 95. Geron Corporation (Geron) Recent Developments
Table 96. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Antisense Oligonucleotide (ASO) Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antisense Oligonucleotide (ASO) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide (ASO) Therapeutics as of 2022)
Table 10. Global Market Antisense Oligonucleotide (ASO) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antisense Oligonucleotide (ASO) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Antisense Oligonucleotide (ASO) Therapeutics Product Type
Table 13. Global Antisense Oligonucleotide (ASO) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antisense Oligonucleotide (ASO) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antisense Oligonucleotide (ASO) Therapeutics Market Challenges
Table 22. Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Type (K Units)
Table 23. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Type (M USD)
Table 24. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Antisense Oligonucleotide (ASO) Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) by Application
Table 30. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size by Application
Table 31. Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application (2019-2024)
Table 35. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Antisense Oligonucleotide (ASO) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Antisense Oligonucleotide (ASO) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Antisense Oligonucleotide (ASO) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Antisense Oligonucleotide (ASO) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 44. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 45. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Ionis Pharmaceuticals, Inc Business Overview
Table 47. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
Table 48. Ionis Pharmaceuticals, Inc Recent Developments
Table 49. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 50. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 51. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Sarpeta Therapeutics Inc. Business Overview
Table 53. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
Table 54. Sarpeta Therapeutics Inc. Recent Developments
Table 55. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 56. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 57. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics SWOT Analysis
Table 59. Biogen Inc Business Overview
Table 60. Biogen Inc Recent Developments
Table 61. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 62. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 63. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Alnylam Pharmaceuticals, Inc Business Overview
Table 65. Alnylam Pharmaceuticals, Inc Recent Developments
Table 66. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 67. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 68. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Antisense Therapeutics Limited Business Overview
Table 70. Antisense Therapeutics Limited Recent Developments
Table 71. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 72. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 73. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Arrowhead Pharmaceuticals Inc. Business Overview
Table 75. Arrowhead Pharmaceuticals Inc. Recent Developments
Table 76. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 77. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 78. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Enzon Pharmaceuticals, Inc. Business Overview
Table 80. Enzon Pharmaceuticals, Inc. Recent Developments
Table 81. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 82. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 83. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Bio-Path Holdings, Inc. Business Overview
Table 85. Bio-Path Holdings, Inc. Recent Developments
Table 86. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 87. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 88. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GlaxoSmithKline PLC Business Overview
Table 90. GlaxoSmithKline PLC Recent Developments
Table 91. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Basic Information
Table 92. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Overview
Table 93. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Geron Corporation (Geron) Business Overview
Table 95. Geron Corporation (Geron) Recent Developments
Table 96. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Antisense Oligonucleotide (ASO) Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antisense Oligonucleotide (ASO) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (M USD)
Figure 11. Antisense Oligonucleotide (ASO) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Antisense Oligonucleotide (ASO) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antisense Oligonucleotide (ASO) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antisense Oligonucleotide (ASO) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Antisense Oligonucleotide (ASO) Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Antisense Oligonucleotide (ASO) Therapeutics by Type in 2023
Figure 20. Market Size Share of Antisense Oligonucleotide (ASO) Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Antisense Oligonucleotide (ASO) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application
Figure 24. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application in 2023
Figure 28. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Antisense Oligonucleotide (ASO) Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Antisense Oligonucleotide (ASO) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antisense Oligonucleotide (ASO) Therapeutics Market Size by Country (M USD)
Figure 11. Antisense Oligonucleotide (ASO) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Antisense Oligonucleotide (ASO) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antisense Oligonucleotide (ASO) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antisense Oligonucleotide (ASO) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Antisense Oligonucleotide (ASO) Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Antisense Oligonucleotide (ASO) Therapeutics by Type in 2023
Figure 20. Market Size Share of Antisense Oligonucleotide (ASO) Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Antisense Oligonucleotide (ASO) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application
Figure 24. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share by Application in 2023
Figure 28. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Antisense Oligonucleotide (ASO) Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Antisense Oligonucleotide (ASO) Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Antisense Oligonucleotide (ASO) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Antisense Oligonucleotide (ASO) Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Antisense Oligonucleotide (ASO) Therapeutics Market Share Forecast by Application (2025-2030)
